Marpai (MRAI) Competitors $1.34 +0.02 (+1.52%) As of 08/8/2025 12:14 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. ATPC, BNR, BDSX, NAKA, PIII, KDLY, BMGL, CCM, BGLC, and BRTXShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Agape ATP (ATPC), Burning Rock Biotech (BNR), Biodesix (BDSX), KindlyMD (NAKA), P3 Health Partners (PIII), Kindly MD (KDLY), Basel Medical Group (BMGL), Concord Medical Services (CCM), BioNexus Gene Lab (BGLC), and Biorestorative Therapies (BRTX). These companies are all part of the "healthcare" industry. Marpai vs. Its Competitors Agape ATP Burning Rock Biotech Biodesix KindlyMD P3 Health Partners Kindly MD Basel Medical Group Concord Medical Services BioNexus Gene Lab Biorestorative Therapies Marpai (NASDAQ:MRAI) and Agape ATP (NASDAQ:ATPC) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations. Does the media prefer MRAI or ATPC? In the previous week, Marpai had 1 more articles in the media than Agape ATP. MarketBeat recorded 2 mentions for Marpai and 1 mentions for Agape ATP. Marpai's average media sentiment score of 0.00 equaled Agape ATP'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Marpai 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agape ATP 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is MRAI or ATPC more profitable? Marpai has a net margin of -85.70% compared to Agape ATP's net margin of -191.34%. Marpai's return on equity of 0.00% beat Agape ATP's return on equity.Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% Agape ATP -191.34%-30.95%-27.00% Which has stronger earnings & valuation, MRAI or ATPC? Agape ATP has lower revenue, but higher earnings than Marpai. Agape ATP is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.64-$28.75M-$1.82-0.74Agape ATP$1.32M51.71-$2.47M-$0.60-2.28 Do insiders and institutionals hold more shares of MRAI or ATPC? 49.8% of Marpai shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 46.1% of Marpai shares are owned by insiders. Comparatively, 9.7% of Agape ATP shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, MRAI or ATPC? Marpai has a beta of 4.66, indicating that its stock price is 366% more volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.97, indicating that its stock price is 197% less volatile than the S&P 500. SummaryMarpai beats Agape ATP on 8 of the 12 factors compared between the two stocks. Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$22.33M$183.19M$22.36B$9.72BDividend YieldN/AN/A2.84%4.12%P/E Ratio-0.511.0528.1524.75Price / Sales0.640.5441.2597.72Price / CashN/A2.8027.1558.47Price / Book-0.780.215.395.59Net Income-$28.75M$43.11M$198.75M$265.99M7 Day Performance13.56%64.61%12.01%5.07%1 Month Performance-1.47%74.59%10.46%0.61%1 Year Performance101.81%18.70%38.08%22.83% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpaiN/A$1.34+1.5%N/A+101.8%$22.33M$34.87M-0.51150News CoverageATPCAgape ATP0.2967 of 5 stars$1.41+1.4%N/A-44.7%$69.51M$1.32M-2.3540Upcoming EarningsGap UpBNRBurning Rock Biotech0.8471 of 5 stars$6.50+5.6%N/A+4.1%$66.21M$70.67M-3.441,390BDSXBiodesix3.7085 of 5 stars$0.42+10.1%$1.75+313.7%-74.8%$56.31M$71.32M-1.46220News CoverageEarnings ReportGap DownNAKAKindlyMDN/A$7.24-4.5%N/AN/A$55.37M$2.72M-9.40N/AEarnings ReportPIIIP3 Health Partners2.3204 of 5 stars$6.92-3.8%$16.25+135.0%-78.5%$51.68M$1.50B-0.15500Upcoming EarningsKDLYKindly MDN/A$7.58+19.4%N/A+505.7%$45.65M$2.47M-9.84N/ABMGLBasel Medical GroupN/A$2.05-0.5%N/AN/A$38.02MN/A0.0036CCMConcord Medical ServicesN/A$5.05-5.4%N/A-37.0%$23.18M$52.60M0.00970Positive NewsGap DownBGLCBioNexus Gene Lab0.0812 of 5 stars$5.73-13.7%N/A+29.1%$11.93M$9.51M0.0030Upcoming EarningsBRTXBiorestorative Therapies3.1733 of 5 stars$1.49+0.7%$18.00+1,108.1%+6.6%$11.11M$400K-1.017Upcoming Earnings Related Companies and Tools Related Companies Agape ATP Competitors Burning Rock Biotech Competitors Biodesix Competitors KindlyMD Competitors P3 Health Partners Competitors Kindly MD Competitors Basel Medical Group Competitors Concord Medical Services Competitors BioNexus Gene Lab Competitors Biorestorative Therapies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 8/10/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.